Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Healthcare Triangle	HCTI	10. jan 2025	1.03	-4.63
HealthEquity	HQY	10. jan 2025	100.32	+0.58
Healthpeak Properties	DOC	10. jan 2025	19.66	-3.25
HealthStream	HSTM	10. jan 2025	31.38	-3.36
Healthy Choice Wellness	HCWC	10. jan 2025	1.84	+52.07
Heartbeam	BEAT	10. jan 2025	2.11	-0.94
Heartcore Enterprises	HTCR	10. jan 2025	1.66	-11.70
Heartland Express	HTLD	10. jan 2025	10.70	-1.02
Heartland Financial E Pref	HTLFP	10. jan 2025	25.20	+0.40
Heartland Financial USA	HTLF	10. jan 2025	60.42	+0.23
HeartSciences	HSCS	10. jan 2025	3.40	-7.86
Hecla Mining	HL	10. jan 2025	5.20	-2.26
Hecla Mining B Pref	HL-B	10. jan 2025	51.75	0.00
Hedge Replication ETF Proshares	HDG	10. jan 2025	49.20	-0.49
Heico	HEI	10. jan 2025	225.57	-0.80
Heico A	HEI-A	10. jan 2025	177.92	-0.53
Heidrick & Struggles International	HSII	10. jan 2025	43.80	-0.88
Helen of Troy	HELE	10. jan 2025	61.98	+5.11
Helios Technologies	HLIO	10. jan 2025	44.00	-4.56
Helius Medical Technologies A	HSDT	10. jan 2025	0.65	-3.15
Helix Acquisition II	HLXB	10. jan 2025	10.50	-3.93
Helix Energy Solutions Group	HLX	10. jan 2025	8.71	-3.76
Hello ADR	MOMO	10. jan 2025	6.70	-2.90
Helmerich & Payne	HP	10. jan 2025	34.26	+4.48
Helport AI Limited - Ordinary Shares	HPAI	10. jan 2025	5.66	-1.74
Hennessy Advisors	HNNA	10. jan 2025	11.57	-6.66
Hennessy Capital Investment VI SPAC A	HCVI	10. jan 2025	10.62	0.00
Hennessy Capital Investment VI Unit	HCVIU	10. jan 2025	10.57	0.00
Henry Schein	HSIC	10. jan 2025	69.67	-1.96
Hepion Pharmaceuticals	HEPA	10. jan 2025	0.51	-8.98

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.